![Enno Spillner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Enno Spillner
Directeur Financier/CFO chez
FORMYCON AG
Fortune : 158 892 $ au 31/05/2026
Profil
Enno Spillner currently works at Concentro Management AG, as Deputy Chairman-Supervisory Board from 2002, Euronext Paris SA, as Non-Executive Director from 2014, Nanobiotix SA, as Member-Supervisory Board from 2014, Formycon AG, as Chief Financial Officer from 2023, and leon-nanodrugs GmbH, as Member-Supervisory Board.
Mr. Spillner also formerly worked at ActiPac Biosystems GmbH, as Managing Director from 1999 to 2000, Munich Innovative Biomaterials GmbH, as Managing Director, Evotec International GmbH, as Co-Managing Director, 4SC AG, as Chief Executive & Financial Officer from 2013 to 2016, Evotec SE, as Chief Financial Officer from 2016 to 2023, Biom Venture Capital GmbH & Co. Fonds KG, as Managing Partner, and BioM AG Munich BioTech Development, as Head-Finance & Controlling.
Mr. Spillner received his graduate degree from the University of Bamberg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NANOBIOTIX SA 0,01 % | 31/03/2026 | 4 000 ( 0,01 % ) | 158 892 $ | 31/05/2026 |
Postes actifs de Enno Spillner
| Sociétés | Poste | Début |
|---|---|---|
| NANOBIOTIX | Directeur/Membre du Conseil | 18/06/2014 |
| FORMYCON AG | Directeur Financier/CFO | 01/04/2023 |
Concentro Management AG
 Concentro Management AG Investment ManagersFinance Provides financial consulting services | Directeur/Membre du Conseil | 11/05/2010 |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Directeur/Membre du Conseil | - |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Operates a stock exchange which provides solutions for regulated stock and derivatives markets in France | Directeur/Membre du Conseil | 01/01/2014 |
Anciens postes connus de Enno Spillner
| Sociétés | Poste | Fin |
|---|---|---|
| EVOTEC SE | Directeur Financier/CFO | 01/03/2023 |
| 4SC AG | Directeur Général | 30/06/2016 |
ActiPac Biosystems GmbH | Directeur Général | 01/03/2000 |
Munich Innovative Biomaterials GmbH
 Munich Innovative Biomaterials GmbH Investment ManagersFinance Functions as a pension/retirement fund | Directeur Général | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Enno Spillner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Evotec International GmbH
 Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Develops and provides drugs specializing in the treatment of CNS disorders | Commercial Services |
Euronext Paris SA
Euronext Paris SA Investment Banks/BrokersFinance Operates a stock exchange which provides solutions for regulated stock and derivatives markets in France | Finance |
BioM AG Munich BioTech Development
 BioM AG Munich BioTech Development Investment ManagersFinance BMBD is a venture capital investment manager specialized in early-stage biotechnology companies with high-growth potential. The firm invests in Europe with a strong focus on the Munich area. They generally co-invest, often in companies first launched through a seed investment from BioM. BMBD generally acquires minority stakes. Their goal is to accompany their portfolio companies into the later stages of development. In addition to capital, the firm provides business support services leveraging BioM's network and capabilities. | Finance |
University of Bamberg
 University of Bamberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biom Venture Capital GmbH & Co. Fonds KG
 Biom Venture Capital GmbH & Co. Fonds KG Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Nanobiotix SA
 Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer | Health Technology |
Concentro Management AG
Concentro Management AG Investment ManagersFinance Provides financial consulting services | Finance |
Formycon AG
 Formycon AG Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Technology Services |
ActiPac Biosystems GmbH | |
Munich Innovative Biomaterials GmbH
Munich Innovative Biomaterials GmbH Investment ManagersFinance Functions as a pension/retirement fund | Finance |
